Literature DB >> 28439154

Analysis of Survival Rates Following Primary Surgery of 178 Consecutive Patients with Oral Cancer in a Large District General Hospital.

Panagiotis Stathopoulos1, William P Smith1.   

Abstract

PURPOSE: The aim of this study is to present the survival rates in patients treated for oral cancer with primary surgery in a large district general hospital. We discuss the influence of the most significant prognostic factors on survival and compare our results with larger centres specializing in the management of oral cancer.
METHODS: All patients diagnosed with oral cancer from 1995 to 2006 and were treated in the Department had their details entered prospectively onto a computerized database. Demographic details of patients, type of treatment, pathological stage of tumor (TNM), local and regional recurrence rate, overall survival, disease specific survival and incidence of involved margins were recorded and calculated.
RESULTS: Of the 178 patients, 96 (54 %) were alive and free of oral cancer 5 years after surgery. Forty-four patients died of oral cancer (24.7 %) but 38 (21.3 %) died of other causes. The overall survival rate after primary surgery in relation to stage was: I 84 %, II 71 %, III 36 % and IV 28 %. DISCUSSION: As almost half of our patients presented with advanced cancer and had discouraging survival rates, we emphasize the need for early recognition of the disease. Advanced disease signifies difficulty in obtaining clear margins which actually indicates a higher recurrence rate. 25 % of our patients died of oral cancer within 5 years of surgery which highlights the poor prognosis that recurrence carries after treatment. Effective educational campaign with purpose to raise oral cancer awareness and earlier referral may result in improvement of survival.

Entities:  

Keywords:  Oral cancer; Recurrence; Surgical margins; Survival rates

Year:  2016        PMID: 28439154      PMCID: PMC5385680          DOI: 10.1007/s12663-016-0937-z

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  32 in total

1.  Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread.

Authors:  J A Woolgar; S N Rogers; D Lowe; J S Brown; E D Vaughan
Journal:  Oral Oncol       Date:  2003-02       Impact factor: 5.337

2.  [Prognostic value of the number of involved nodes after neck dissection in oropharyngeal and oral cavity carcinoma].

Authors:  F Denis; P Garaud; A Manceau; P Beutter; G Garand; O le Floch; G Calais
Journal:  Cancer Radiother       Date:  2001 Jan-Feb       Impact factor: 1.018

3.  Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma.

Authors:  Paolo Garzino-Demo; Alessandro Dell'Acqua; Paola Dalmasso; Massimo Fasolis; Gian Marco La Terra Maggiore; Guglielmo Ramieri; Sid Berrone; Monica Rampino; Marina Schena
Journal:  J Craniomaxillofac Surg       Date:  2006-07-21       Impact factor: 2.078

4.  [The value of extemporaneous study of the surgical margins of cancers of the upper aero-digestive tract. Apropos of 129 cases of oral and oropharyngeal tumors].

Authors:  P Barrellier; P Dupin; B Grimaux; F Blanchet; A Notari; J P Rame; D De Raucourt; A M Mandard; E De Ranieri; J F Compere
Journal:  Rev Stomatol Chir Maxillofac       Date:  1991

5.  Mortality and causes of death after multimodality treatment for advanced oral and oropharyngeal cancer.

Authors:  Arno Wutzl; Oliver Ploder; Christian Kermer; Werner Millesi; Rolf Ewers; Clemens Klug
Journal:  J Oral Maxillofac Surg       Date:  2007-02       Impact factor: 1.895

6.  Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread.

Authors:  R L Carter; J M Bliss; K C Soo; C J O'Brien
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-06       Impact factor: 7.038

7.  Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology.

Authors:  Pieter J Slootweg; Gert Jan Hordijk; Yolanda Schade; Robert J J van Es; Ronald Koole
Journal:  Oral Oncol       Date:  2002-07       Impact factor: 5.337

8.  [Retrospective analysis of the prognostic significance of depth of invasion of advanced oral and oropharyngeal squamous cell carcinomas with lymph node metastases].

Authors:  S Wenzel; C Sagowski; W Kehrl; F U Metternich
Journal:  HNO       Date:  2004-07       Impact factor: 1.284

9.  A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer.

Authors:  F Carinci; S Pelucchi; A Farina; C Calearo
Journal:  J Oral Maxillofac Surg       Date:  1998-07       Impact factor: 1.895

10.  Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery.

Authors:  A S Jones; Z Bin Hanafi; V Nadapalan; N J Roland; A Kinsella; T R Helliwell
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more
  4 in total

1.  The dental management of a mouth cancer patient.

Authors:  N G Beacher; M P Sweeney
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

2.  Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer.

Authors:  Ana Caruntu; Liliana Moraru; Diana Alina Ciubotaru; Cristiana Tanase; Cristian Scheau; Constantin Caruntu
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

3.  Diagnosis and referral delays in primary care for oral squamous cell cancer: a systematic review.

Authors:  Ciaran Grafton-Clarke; Kai Wen Chen; Jane Wilcock
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

4.  Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma.

Authors:  Ana Caruntu; Liliana Moraru; Mihai Lupu; Florina Vasilescu; Marius Dumitrescu; Mirela Cioplea; Cristiana Popp; Alexandra Dragusin; Constantin Caruntu; Sabina Zurac
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.